asked the Minister of Health what changes he intends to make in the voluntary price regulation scheme for drugs following his review of the scheme.

This matter is still under consideration.

Is the right hon. Gentleman aware that, in the light of the very sharp criticisms of the scheme by the Public Accounts Committee and the excessive profits of some drug manufacturers, we look forward to substantial changes in the scheme? Is he able to tell the House when he is likely to make an announcement on this matter?

Not yet, Sir.